These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 476986

  • 21. Antithyroid drugs and their analogues: synthesis, structure, and mechanism of action.
    Manna D, Roy G, Mugesh G.
    Acc Chem Res; 2013 Nov 19; 46(11):2706-15. PubMed ID: 23883148
    [Abstract] [Full Text] [Related]

  • 22. Acute pancreatitis caused by methimazole/carbimazole assumption: a case-series.
    Sarro A, Esposito R, Zibetti A, Pecere A.
    Minerva Endocrinol (Torino); 2023 Mar 19; 48(1):115-120. PubMed ID: 34825556
    [Abstract] [Full Text] [Related]

  • 23. Comparative In Vitro Effects and In Vivo Kinetics of Antithyroid Drugs.
    Melander A, Hallengren B, Rosendal-Helgesen S, Sjöberg AK, Wählin-Boll E.
    Eur J Clin Pharmacol; 1980 Apr 19; 17(4):295-9. PubMed ID: 6156842
    [No Abstract] [Full Text] [Related]

  • 24. Methimazole pharmacology in the rat: studies using a newly developed radioimmunoassay for methimazole.
    Cooper DS, Kieffer JD, Saxe V, Mover H, Maloof F, Ridgway EC.
    Endocrinology; 1984 Mar 19; 114(3):786-93. PubMed ID: 6199191
    [Abstract] [Full Text] [Related]

  • 25. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
    Takata K, Amino N, Kubota S, Sasaki I, Nishihara E, Kudo T, Ito M, Fukata S, Miyauchi A.
    Clin Endocrinol (Oxf); 2010 Jun 19; 72(6):845-50. PubMed ID: 19912243
    [Abstract] [Full Text] [Related]

  • 26. Studies of thyroid hormone and methimazole levels in patients with Graves' disease on a standardized anti-thyroid drug regimen.
    Dahlberg PA, Karlsson FA, Lindström B, Wide L.
    Clin Endocrinol (Oxf); 1981 Jun 19; 14(6):555-62. PubMed ID: 6895351
    [Abstract] [Full Text] [Related]

  • 27. Methimazole pharmacology in man: studies using a newly developed radioimmunoassay for methimazole.
    Cooper DS, Bode HH, Nath B, Saxe V, Maloof F, Ridgway EC.
    J Clin Endocrinol Metab; 1984 Mar 19; 58(3):473-9. PubMed ID: 6546390
    [Abstract] [Full Text] [Related]

  • 28. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, Lian WC, Huang WS, Kuo SW.
    Clin Endocrinol (Oxf); 2004 Jun 19; 60(6):676-81. PubMed ID: 15163329
    [Abstract] [Full Text] [Related]

  • 29. Preferential inhibition of thyroxine and 3,5,3'-triiodothyronine formation by propylthiouracil and methylmercaptoimidazole in thyroid peroxidase-catalyzed iodination of thyroglobulin.
    Engler H, Taurog A, Dorris ML.
    Endocrinology; 1982 Jan 19; 110(1):190-7. PubMed ID: 7053983
    [Abstract] [Full Text] [Related]

  • 30. Intrathyroidal concentrations of methimazole in patients with Graves' disease.
    Jansson R, Dahlberg PA, Johansson H, Lindström B.
    J Clin Endocrinol Metab; 1983 Jul 19; 57(1):129-32. PubMed ID: 6687892
    [Abstract] [Full Text] [Related]

  • 31. Intrathyroidal iodide binding rates and plasma methimazole concentrations in hyperthyroid patients on small doses of carbimazole.
    Low LC, McCruden DC, Alexander WD, Hilditch TE, Skellern GG, Knight BI.
    Br J Clin Pharmacol; 1981 Sep 19; 12(3):315-8. PubMed ID: 7295461
    [Abstract] [Full Text] [Related]

  • 32. Carbimazole and the autoimmune response in Graves' disease.
    McGregor AM, Petersen MM, McLachlan SM, Rooke P, Smith BR, Hall R.
    N Engl J Med; 1980 Aug 07; 303(6):302-7. PubMed ID: 6247656
    [Abstract] [Full Text] [Related]

  • 33. [The occurrence of agranulocytosis due to antithyroid drugs in a cohort of patients with Graves disease treated with radioactive iodine 131I during 14 years].
    Cepková J, Gabalec F, Svilias I, Horáček J.
    Vnitr Lek; 2014 Oct 07; 60(10):832-6. PubMed ID: 25382005
    [Abstract] [Full Text] [Related]

  • 34. Methimazole as an antioxidant and immunomodulator in thyroid cells: mechanisms involving interferon-gamma signaling and H(2)O(2) scavenging.
    Kim H, Lee TH, Hwang YS, Bang MA, Kim KH, Suh JM, Chung HK, Yu DY, Lee KK, Kwon OY, Ro HK, Shong M.
    Mol Pharmacol; 2001 Nov 07; 60(5):972-80. PubMed ID: 11641425
    [Abstract] [Full Text] [Related]

  • 35. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
    Yoshihara A, Noh JY, Watanabe N, Mukasa K, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Suzuki N, Kameda T, Iwaku K, Kobayashi S, Sugino K, Ito K.
    Thyroid; 2015 Oct 07; 25(10):1155-61. PubMed ID: 26222916
    [Abstract] [Full Text] [Related]

  • 36. Coupling of iodotyrosine catalyzed by human thyroid peroxidase in vitro.
    Sugawara M.
    J Clin Endocrinol Metab; 1985 Jun 07; 60(6):1069-75. PubMed ID: 3838997
    [Abstract] [Full Text] [Related]

  • 37. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
    Nakazato N, Yoshida K, Mori K, Kiso Y, Sayama N, Tani JI, Nakagawa Y, Ito S.
    Thyroid; 1999 Aug 07; 9(8):775-9. PubMed ID: 10482369
    [Abstract] [Full Text] [Related]

  • 38. A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats.
    Motonaga K, Ota M, Odawara K, Saito S, Welsch F.
    Regul Toxicol Pharmacol; 2016 Oct 07; 80():283-90. PubMed ID: 27350053
    [Abstract] [Full Text] [Related]

  • 39. Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves' disease.
    Roti E, Robuschi G, Gardini E, Montermini M, Salvi M, Manfredi A, Gnudi A, Braverman LE.
    Clin Endocrinol (Oxf); 1988 Mar 07; 28(3):305-14. PubMed ID: 3168311
    [Abstract] [Full Text] [Related]

  • 40. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
    Huang CN, Hsu TC, Chou HH, Tsay GJ.
    J Formos Med Assoc; 2004 Apr 07; 103(4):274-9. PubMed ID: 15175822
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.